461.60
Medpace Holdings Inc stock is traded at $461.60, with a volume of 224.69K.
It is down -1.26% in the last 24 hours and up +11.16% over the past month.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
See More
Previous Close:
$467.50
Open:
$467.64
24h Volume:
224.69K
Relative Volume:
0.62
Market Cap:
$13.18B
Revenue:
$2.68B
Net Income/Loss:
$460.40M
P/E Ratio:
29.04
EPS:
15.8963
Net Cash Flow:
$711.00M
1W Performance:
-1.11%
1M Performance:
+11.16%
6M Performance:
-17.39%
1Y Performance:
+53.37%
Medpace Holdings Inc Stock (MEDP) Company Profile
Name
Medpace Holdings Inc
Sector
Industry
Phone
(513) 579-9911
Address
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MEDP
Medpace Holdings Inc
|
461.60 | 13.35B | 2.68B | 460.40M | 711.00M | 15.90 |
|
TMO
Thermo Fisher Scientific Inc
|
472.63 | 176.04B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
181.35 | 128.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
573.00 | 44.96B | 4.45B | 1.10B | 1.06B | 13.59 |
|
A
Agilent Technologies Inc
|
128.34 | 36.88B | 7.23B | 1.41B | 1.09B | 4.979 |
|
WAT
Waters Corp
|
360.54 | 35.13B | 3.77B | 449.25M | 240.68M | 7.8556 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Upgrade | Barclays | Underweight → Equal Weight |
| Mar-03-26 | Initiated | RBC Capital Mkts | Outperform |
| Feb-18-26 | Upgrade | TD Cowen | Sell → Hold |
| Feb-13-26 | Upgrade | Jefferies | Hold → Buy |
| Feb-10-26 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-02-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-03-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jul-29-25 | Downgrade | UBS | Neutral → Sell |
| Jul-23-25 | Downgrade | TD Cowen | Hold → Sell |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Apr-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-24-25 | Initiated | Leerink Partners | Market Perform |
| Oct-23-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-27-24 | Downgrade | UBS | Buy → Neutral |
| Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-01-24 | Initiated | Truist | Hold |
| May-29-24 | Initiated | TD Cowen | Buy |
| May-28-24 | Initiated | Mizuho | Buy |
| Apr-23-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-24 | Initiated | Deutsche Bank | Hold |
| Feb-15-24 | Upgrade | UBS | Neutral → Buy |
| Oct-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-08-23 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-27-22 | Upgrade | UBS | Sell → Neutral |
| Sep-07-22 | Initiated | UBS | Sell |
| May-24-22 | Initiated | Guggenheim | Neutral |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Oct-02-20 | Upgrade | Truist | Hold → Buy |
| Jun-08-20 | Upgrade | Robert W. Baird | Underperform → Neutral |
| May-13-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-30-20 | Upgrade | SunTrust | Sell → Hold |
| Apr-20-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Mar-17-20 | Downgrade | SunTrust | Hold → Sell |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Oct-31-18 | Upgrade | SunTrust | Hold → Buy |
| Sep-17-18 | Initiated | SunTrust | Hold |
| Jul-31-18 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-29-17 | Initiated | Raymond James | Mkt Perform |
| Jul-10-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Medpace Holdings Inc Stock (MEDP) Latest News
Medpace (MEDP) Stock Weighing Modest Undervaluation Against Rich P/E And Mixed Momentum - Yahoo Finance
MEDP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Medpace Holdings, Inc. (MEDP) And Encourages Investors to Reach Out - ACCESS Newswire
Madison Small Cap Fund Increased Medpace Holdings (MEDP), Downplaying AI Fears - Insider Monkey
Cerity Partners LLC Buys 23,530 Shares of Medpace Holdings, Inc. $MEDP - MarketBeat
Franklin Resources Inc. Has $168.20 Million Stake in Medpace Holdings, Inc. $MEDP - MarketBeat
CenterBook Partners LP Sells 2,693 Shares of Medpace Holdings, Inc. $MEDP - MarketBeat
Why the Market Dipped But Medpace (MEDP) Gained Today - Yahoo Finance
Bank of New York Mellon Corp Has $89.57 Million Holdings in Medpace Holdings, Inc. $MEDP - MarketBeat
Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - PR Newswire
MEDP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026 - News-Press NOW
MEDPACE DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important June 8 Deadline in Securities Class ActionMEDP - ACCESS Newswire
Safirstein Law LLC Announces That A Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP) - GlobeNewswire Inc.
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Highlights Class Action Against Medpace Holdings (MEDP) and Upcoming Lead Plaintiff Deadline of June 8, 2026 - bastillepost.com
Medpace Holdings, Inc. (MEDP) Stock Analysis: Decoding the Growth Potential in Healthcare Research - DirectorsTalk Interviews
MEDP DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. ... - Black Hills Pioneer
INVESTOR DEADLINE: Medpace Holdings Inc. (MEDP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - marketscreener.com
How Investors Are Reacting To Medpace Holdings (MEDP) Executive Shakeup Amid Securities Class Action Surge - simplywall.st
MEDP DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important June 8 Deadline in Securities Class Action - GlobeNewswire Inc.
MEDP UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026 - TMX Newsfile
Debt to assets ratio of Medpace Holdings, Inc. – XETR:01P - TradingView
Price to earnings ratio of Medpace Holdings, Inc. – XETR:01P - TradingView
Medpace Holdings' high P/E ratio may not be justified given its average growth outlook, potentially leaving shareholders exposed to a price correction. Investors should be cautious, as the stock appears overvalued relative to expected earnings. - Moomoo
Total liabilities of Medpace Holdings, Inc. – XETR:01P - TradingView
ETFs Investing in Medpace Holdings, Inc. Stocks - TradingView
Medpace Holdings, Inc. Balance Sheet – XETR:01P - TradingView
Medpace Holdings, Inc. Cash Flow – XETR:01P - TradingView
MONDAY INVESTOR DEADLINE: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP AnnouncesMEDP - The Malaysian Reserve
How Investors May Respond To Medpace (MEDP) Lawsuits And EVP Shift In Operating Leadership - Yahoo Finance
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have O - GuruFocus
Medpace Elevates Brad Hansman to Executive Operations Role - The Globe and Mail
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
MEDP Deadline: Rosen Law Firm Urges Medpace Holdings, Inc. (NASDAQ: MEDP) Stockholders to Contact the Firm for Information About Their Rights - Caledonian Record
MEDP Shareholder Alert: Medpace Holdings, Inc. Securities - GlobeNewswire
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Laws - GuruFocus
Press releases provided by CNW - Techaeris
ROSEN, A LEADING LAW FIRM, Encourages Veritone, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
MEDPACE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors ... - Caledonian Record
MEDPACE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class Action - GlobeNewswire Inc.
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Company Allegedly Overstated Growth Projections: SueWallSt – Company Announcement - Financial Times
Medpace (MEDP) Exec VP Brad Hansman reports stock, option and RSU holdings - Stock Titan
MEDPACE HOLDINGS DEADLINE TOMORROW JUNE 5th: Bragar Eagel & - GlobeNewswire
Medpace Deadline: MEDP Investors with Losses in Excess of $100K - GuruFocus
Medpace Holdings, Inc. Announces Appointment of Brad W. Hansman to Executive Vice President, Operations, Effective June 1, 2026 - marketscreener.com
Medpace (NASDAQ: MEDP) appoints Brad Hansman as EVP of operations - Stock Titan
Medpace Deadline: MEDP Investors with Losses in Excess of $100K Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit - PR Newswire
MEDP DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Medpace Holdings, Inc. Investors to Join the Class Action Lawsuit Today - ACCESS Newswire
symbol__ Stock Quote Price and Forecast - CNN
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming DeadlinesMEDP - PR Newswire
INVESTOR DEADLINE MONDAY: Medpace Holdings Inc. (MEDP) Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitRGRD Law - marketscreener.com
Medpace Holdings Inc Stock (MEDP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Medpace Holdings Inc Stock (MEDP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| EWALD STEPHEN P | General Counsel & Corp. Secy. |
May 28 '26 |
Sale |
450.00 |
16,349 |
7,357,050 |
20,343 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):